Clinical Trial Update: Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is testing intraperitoneal immune checkpoint inhibitors with zoledronic acid for gastric cancer with malignant ascites, and the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Malignant Ascites

Drugs mentioned

• Zoledronic acid (Zoledronic acid)
• intraperitoneal immune checkpoint inhibitors

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Cancer of Stomach, Adenocarcinoma, Ascites, Malignant | Phase 1, Phase 2 | Status: RECRUITING